| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

BofA Downgrades Texas Instruments to Underperform, Citing Limited AI Exposure and Tariff Risks

BofA Securities downgraded Texas Instruments (NASDAQ: TXN) from Neutral to Underperform and lowered its price target to $190.00 from $208.00, warning that global tariffs and limited participation in the AI investment cycle could constrain near-term growth.

The firm said that while it continued to recognize the company’s strong execution and asset quality, ongoing trade-related disruptions could hinder demand recovery in the industrial economy. Unlike peers such as Infineon (IFX), Texas Instruments had minimal exposure to AI-related capital expenditures, according to BofA.

Analysts noted that the stock’s valuation appeared stretched, trading at 25x consensus and 31x BofA’s calendar year 2026 earnings estimates—higher than Analog Devices (ADI) despite weaker free cash flow generation.

BofA trimmed its 2026 and 2027 earnings estimates by 3% each, to $6.05 and $6.91 per share, representing 8% and 13% below Street consensus, respectively.

Published on: October 13, 2025